| # | Drug | Count |
|---|---|---|
| 0 | DROSPIRENONE AND ETHINYL ESTRADIOL | 149 |
| 1 | DEXAMETHASONE | 133 |
| 2 | DEXAMETHASONE 1.5 MG | 133 |
| 3 | CYCLOPHOSPHAMIDE | 122 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 122 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 122 |
| 6 | PREDNISONE | 103 |
| 7 | METHOTREXATE SODIUM | 101 |
| 8 | METHOTREXATE | 95 |
| 9 | FUROSEMIDE | 83 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAGULATION FACTOR X HUMAN | 1 | 0.0286 |
| 1 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 2 | 0.0123 |
| 2 | NAFARELIN ACETATE | 2 | 0.0073 |
| 3 | CHORIONIC GONADOTROPIN | 4 | 0.0071 |
| 4 | HETASTARCH | 1 | 0.0059 |
| 5 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 6 | ZIV-AFLIBERCEPT | 6 | 0.0046 |
| 7 | ANDEXANET ALFA | 3 | 0.0042 |
| 8 | BIVALIRUDIN | 4 | 0.0040 |
| 9 | FOLLITROPIN ALFA | 8 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 307 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 182 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 176 |
| 3 | Platinum-based Drug [EPC] | 151 |
| 4 | Alkylating Drug [EPC] | 147 |
| 5 | Proton Pump Inhibitor [EPC] | 140 |
| 6 | Factor Xa Inhibitor [EPC] | 119 |
| 7 | Benzodiazepine [EPC] | 109 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 104 |
| 9 | Microtubule Inhibitor [EPC] | 99 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 1 | 0.0096 |
| 1 | Human C1 Esterase Inhibitor [EPC] | 12 | 0.0031 |
| 2 | CD22-directed Immunoconjugate [EPC] | 8 | 0.0027 |
| 3 | Asparagine-specific Enzyme [EPC] | 33 | 0.0024 |
| 4 | Autologous Cellular Immunotherapy [EPC] | 14 | 0.0024 |
| 5 | Anti-coagulant [EPC] | 8 | 0.0021 |
| 6 | Hematopoietic Stem Cell Mobilizer [EPC] | 3 | 0.0020 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 13 | 0.0015 |
| 8 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 9 | 0.0014 |